California’s generic insulin struggles to gain traction
California’s generic insulin program, CalRx, offers affordable insulin at $55 but faces slow adoption despite lower costs. Learn why.
Husband Kicked From Hospice for Dying Too Slowly
Husband Kicked From Hospice for Dying Too Slowly: A story of unfair treatment and family struggle as a man battles…
Public weighs in on opioid funds and work rules
New Mexico struggles to spend $100M in opioid funds due to workforce shortages and procurement delays, delaying critical treatment programs.
Federal Rule Hinders Opioid Fight
Federal rules hinder opioid fight efforts, posing challenges to addressing overdose incidents with harmful substances like N-methylclonazepam.
Medicare Advantage firm settles billing case for $342M
A Medicare Advantage insurer pays $342M to settle overbilling allegations, signaling stricter regulatory oversight for the program.
Opioid funds spark Capitol budget fight
Washington D.C. faces backlash for redirecting opioid settlement funds to Medicaid, sparking a budget battle over addiction treatment priorities.
Cyclospora cases spark fears of deadlier outbreaks
Rising Cyclospora cases highlight gaps in food safety surveillance, risking undetected deadly outbreaks amid budget cuts.
Work rules leave homeless without Medicaid
Medicaid work rules often strip coverage from homeless individuals, exacerbating health crises and leaving vulnerable populations without essential support.
Baltimore Reimagines 911 Calls and Response Teams
Baltimore is rethinking its 911 system to send mental health professionals instead of police. Learn how the city uses opioid…